S2-E25.3 (CORRECTED) - Prevalence of NAFLD and NASH 2021 -- An Urgent Call to Action

Send us a text

(This episode has been reposted to include the complete conversation content.)

Louise Campbell and Roger Green join co-authors Stephen Harrison, Naim Alkhouri and first-time guest Prof. Samer Gowrieh to discuss why this epidemiology paper from the 2021 Journal of Hepatology is an urgent call to action on NAFLD and NASH screening and treatment. 

Considered in its totality, the data emerging from the 2021 Journal of Hepatology paper "Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort" come across as a clarion call to screen unaware, asymptomatic patients more aggressively and treat them more intently, even before we have new, approved medications in market. Whether you are familiar with the paper or not, you will want to hear why the panelists consider this data so compelling and the call to action so urgent.